Výsledky vyhledávání - "Hayden Christie"

C-POST protocol update: A Phase 3, randomized, double-blind study of adjuvant cemiplimab versus placebo post surgery and radiation therapy in patients with high-risk cutaneous squamous cell carcinoma

Autor: Danny Rischin, Daniel Brungs, Fiona Day, Hayden Christie, Vishal Patel, Gerard Adams, James Estes Jackson, Maite De Liz Vassen Schurmann, Dmitry Kirtbaya, Thuzar Shin, Christopher Hart, Elizabeth Stankevich, Siyu Li, Israel Lowy, Hyunsil Han, Priscila Gonçalves, Matthew Fury, Sandro Porceddu

Publikováno v: SKIN The Journal of Cutaneous Medicine. 7:s173

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f76e006698c269fe83f0c93e1911a7fe
https://doi.org/10.25251/skin.7.supp.173

Zobrazit plný text záznamu

Two cases of clinical myasthenia gravis associated with pembrolizumab use in responding melanoma patients

Autor: Bella H V Nguyen, James Kuo, Anadian Budiman, Sayed Ali, Hayden Christie

Publikováno v: Melanoma research. 27(2)

Immune checkpoint inhibitors have changed the landscape of the treatment of multiple solid malignancies, and have been used increasingly in the recent years. Although usually well tolerated, given the relative inexperience of using immune checkpoint

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04935a134ea0b3718b07f13d8d567942
https://pubmed.ncbi.nlm.nih.gov/27776019

Zobrazit plný text záznamu

Chemotherapy in the elderly (≥65) cancer patient: The relationship between premorbid level of function and treatment tolerance in a metropolitan Australian hospital

Autor: Hayden Christie, Jasotha Sanmugarajah, Katherine Mary Lovat

Publikováno v: Journal of Clinical Oncology. 31:e20706-e20706

e20706 Background: The proportion of elderly patients treated by oncologists is gradually increasing due to demographic changes. This section of the population is generally underrepresented in clinical trials. This results in minimal guidance to dosa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::562bfd1fe60a3d0e838e7934e029632d
https://doi.org/10.1200/jco.2013.31.15_suppl.e20706

Zobrazit plný text záznamu

Adjuvant chemotherapy for early-stage breast cancer: Choice of regimen and associated hematologic toxicities in a metropolitan Australian hospital

Autor: Katherine Mary Lovat, Hayden Christie, Andrew G. Hill, Jasotha Sanmugarajah, Ricky Che

Publikováno v: Journal of Clinical Oncology. 30:123-123

123 Background: The commonly used adjuvant chemotherapy regimens for early breast cancer include 5-fluorouracil, epirubicin, cyclophosphamide and docetaxel (FEC-D), docetaxel and cyclophosphamide (TC), doxorubicin and cyclophosphamide with or without

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d319caa5b628cf9c0483287872fa3aca
https://doi.org/10.1200/jco.2012.30.27_suppl.123

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání